Ptc Therapeutics (PTCT) Change in Cash (2012 - 2026)

Ptc Therapeutics' Change in Cash history runs 15 years deep, the most recent figure standing at -$147.9 million for Q1 2026.

• In Q1 2026, Change in Cash fell 121.11% year-over-year to -$147.9 million; the TTM figure through Mar 2026 stood at -$645.4 million (down 169.31% YoY), while the FY2025 annual figure was $203.0 million, up 9.72% from the prior year.
• Change in Cash was -$147.9 million for Q1 2026 at Ptc Therapeutics, down from $312.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $700.5 million in Q1 2025 to a low of -$462.8 million in Q2 2025.
• Historically, Change in Cash has averaged $38.4 million across 5 years, with a median of -$43.1 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Change in Cash jumped 175514.0% in 2022, then plunged 545.34% in 2025.
• A 5-year view of Change in Cash shows it stood at $175.4 million in 2022, then jumped by 144.49% to $428.9 million in 2023, then slumped by 40.42% to $255.5 million in 2024, then gained by 22.11% to $312.0 million in 2025, then tumbled by 147.4% to -$147.9 million in 2026.
• The last three Change in Cash figures came in at -$147.9 million (Q1 2026), $312.0 million (Q4 2025), and -$346.8 million (Q3 2025), per Business Quant data.